Orzel Spolka Akcyjna Past Earnings Performance
Past criteria checks 1/6
Orzel Spolka Akcyjna has been growing earnings at an average annual rate of 15.4%, while the Chemicals industry saw earnings growing at 21.3% annually. Revenues have been growing at an average rate of 11% per year. Orzel Spolka Akcyjna's return on equity is 19.3%, and it has net margins of 14.2%.
Key information
15.4%
Earnings growth rate
8.6%
EPS growth rate
| Chemicals Industry Growth | 32.6% |
| Revenue growth rate | 11.0% |
| Return on equity | 19.3% |
| Net Margin | 14.2% |
| Next Earnings Update | 17 May 2024 |
Recent past performance updates
Recent updates
Calculating The Fair Value Of Orzel Spolka Akcyjna (WSE:ORL)
Dec 22
If EPS Growth Is Important To You, Orzel Spolka Akcyjna (WSE:ORL) Presents An Opportunity
Sep 29Should You Be Adding Orzel Spolka Akcyjna (WSE:ORL) To Your Watchlist Today?
May 13If You Like EPS Growth Then Check Out Orzel Spolka Akcyjna (WSE:ORL) Before It's Too Late
Jan 25Estimating The Fair Value Of Orzel Spolka Akcyjna (WSE:ORL)
Aug 03A Look At The Fair Value Of Orzel Spolka Akcyjna (WSE:ORL)
Mar 12Orzel Spolka Akcyjna (WSE:ORL) Has A Somewhat Strained Balance Sheet
Dec 11
Revenue & Expenses BreakdownBeta
How Orzel Spolka Akcyjna makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 17 | 2 | 4 | 0 |
| 30 Sep 23 | 18 | 3 | 4 | 0 |
| 30 Jun 23 | 16 | 2 | 4 | 0 |
| 31 Mar 23 | 15 | 2 | 4 | 0 |
| 31 Dec 22 | 15 | 3 | 4 | 0 |
| 30 Sep 22 | 14 | 2 | 4 | 0 |
| 30 Jun 22 | 14 | 2 | 3 | 0 |
| 31 Mar 22 | 14 | 3 | 3 | 0 |
| 31 Dec 21 | 13 | 3 | 3 | 0 |
| 30 Sep 21 | 12 | 2 | 3 | 0 |
| 30 Jun 21 | 12 | 2 | 3 | 0 |
| 31 Mar 21 | 12 | 1 | 3 | 0 |
| 31 Dec 20 | 11 | 1 | 3 | 0 |
| 30 Sep 20 | 11 | 1 | 3 | 0 |
| 30 Jun 20 | 11 | 2 | 3 | 0 |
| 31 Mar 20 | 11 | 2 | 3 | 0 |
| 31 Dec 19 | 12 | 2 | 3 | 0 |
| 30 Sep 19 | 11 | 2 | 2 | 0 |
| 30 Jun 19 | 11 | 1 | 2 | 0 |
| 31 Mar 19 | 10 | 1 | 2 | 0 |
| 31 Dec 18 | 10 | 1 | 2 | 0 |
| 30 Sep 18 | 11 | 0 | 2 | 0 |
| 30 Jun 18 | 10 | 0 | 3 | 0 |
| 31 Mar 18 | 9 | -1 | 3 | 0 |
| 31 Dec 17 | 9 | -1 | 3 | 0 |
| 30 Sep 17 | 8 | -2 | 3 | 0 |
| 30 Jun 17 | 8 | -2 | 3 | 0 |
| 31 Mar 17 | 7 | -2 | 3 | 0 |
| 31 Dec 16 | 6 | -1 | 3 | 0 |
| 30 Sep 16 | 6 | -2 | 6 | 0 |
| 30 Jun 16 | 6 | -1 | 6 | 0 |
| 31 Mar 16 | 6 | -2 | 6 | 0 |
| 31 Dec 15 | 6 | -2 | 6 | 0 |
| 30 Sep 15 | 6 | -3 | 3 | 0 |
| 30 Jun 15 | 6 | -3 | 3 | 0 |
| 31 Mar 15 | 6 | -4 | 2 | 0 |
| 31 Dec 14 | 7 | -5 | 3 | 0 |
| 30 Sep 14 | 17 | -3 | 4 | 0 |
| 30 Jun 14 | 23 | -4 | 5 | 0 |
| 31 Mar 14 | 31 | -3 | 7 | 0 |
| 31 Dec 13 | 34 | -4 | 7 | 0 |
| 30 Sep 13 | 37 | -5 | 7 | 0 |
| 30 Jun 13 | 34 | -4 | 7 | 0 |
Quality Earnings: ORL has a high level of non-cash earnings.
Growing Profit Margin: ORL's current net profit margins (14.2%) are lower than last year (16.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ORL has become profitable over the past 5 years, growing earnings by 15.4% per year.
Accelerating Growth: ORL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ORL had negative earnings growth (-5%) over the past year, making it difficult to compare to the Chemicals industry average (-5%).
Return on Equity
High ROE: ORL's Return on Equity (19.3%) is considered low.